Primary Record
Actein
- In stock
- 3,458 g
- Purity
- 99.1 %
- CAS
- 18642-44-9
Compound Identifiers & Properties
- CAS
- 18642-44-9
- PubChem CID
- 10032468
- SMILES
- C[C@@H]1C[C@@]2([C@H]3[C@](O3)([C@H](O2)O)C)O[C@@H]4[C@H]1[C@]5([C@@H](C[C@@]67C[C@@]68CC[C@@H](C([C@@H]8CC[C@H]7[C@@]5(C4)C)(C)C)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)OC(=O)C)C
- Canonical SMILES
- CC(=O)O[C@@H]1C[C@@]23C[C@@]24CC[C@H](O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)C(C)(C)[C@@H]4CC[C@H]3[C@]2(C)C[C@@H]3O[C@]4(C[C@@H](C)[C@@H]3[C@@]12C)O[C@H](O)[C@@]1(C)O[C@@H]41
Names & Synonyms
- Actein
- Shengmating
- 18642-44-9
- I14QO4LW9V
- RefChem:26274
- UNII-I14QO4LW9V
- ACTEIN [USP-RS]
- ACTEIN [WHO-DD]
- 26S-ACTEIN
- DTXSID7033153
- C37H56O11
- NEWMWGLPJQHSSQ-PSDKAYTQSA-N
- ACTEIN, (-)-
- MEGxp0_000289
- orb1299995
- CHEMBL3391990
- SCHEMBL12311788
- ACon0_000183
- ACon1_001879
- CHEBI:70241
- DTXCID90819961
- MFCD25371991
- HY-N6872
- EX-A10729
- NP7187
- ZINC95627840
- AKOS032962095
- EA65593
- EBC-615888
- C37-H56-O11
- CID10032468
- NCGC00180046-01
- CID 10394764
- CID:10032468
- DA-60791
- MS-31074
- SID:53790919
- 9,19-Cyclolanostane-beta-D-xylopyranoside
- CS-0082050
- W2422
- A939037
- C096064
- BRD-K55497146-001-01-0
- Q27138579
- [(1S,1'R,2S,3'R,4R,4'R,5R,5'R,6'R,10'S,12'S,13'S,16'R,18'S,21'R)-2-hydroxy-1,4',6',12',17',17'-hexamethyl-18'-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8'-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosane]-3'-yl] acetate
- 26S-ACTEIN (CONSTITUENT OF BLACK COHOSH) [DSC]
- b-D-Xylopyranoside,(3b,12b,16b,23R,24R,25S,26S)-12-(acetyloxy)-16,23:23,26:24,25-triepoxy-26-hydroxy-9,19-cyclolanostan-3-yl
- Actein, United States Pharmacopeia (USP) Reference Standard
- ((1S,1'R,2S,3'R,4R,4'R,5R,5'R,6'R,10'S,12'S,13'S,16'R,18'S,21'R)-2-hydroxy-1,4',6',12',17',17'-hexamethyl-18'-((2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl)oxyspiro(3,6-dioxabicyclo(3.1.0)hexane-4,8'-9-oxahexacyclo(11.9.0.01,21.04,12.05,10.016,21)docosane)-3'-yl) acetate
- (1'R,2S,2'R,4'S,4aR,5'S,5aR,7R,7aR,7bR,8R,11aS,12aS,12bS,14aR)-4'-Hydroxy-1,1,5',7a,8,12a-hexamethyl-2-(beta-D-xylopyranosyloxy)hexadecahydro-2H,5H-spiro[cyclopropa[1',8'a]naphtho[2',1':4,5]indeno[2,1-b]pyran-10,2'-[3,6]dioxabicyclo[3.1.0]hexan]-7-yl acetate
- (1R,1'R,2R,3'R,4S,4'R,5S,5'R,6'R,10'S,12'S,13'S,16'R,18'S,21'R)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0^{1,21}.0^{4,12}.0^{5,10}.0^{16,21}]docosan]-3'-yl acetate
- .beta.-D-Xylopyranoside, (3.beta.,12.beta.)-12-(acetyloxy)-16,23:23,26:24,25-triepoxy-26-hydroxy-9,19-cyclolanostan-3-yl
- .BETA.-D-XYLOPYRANOSIDE, (3.BETA.,12.BETA.,16.BETA.,23R,24R,25S,26S)-12-(ACETYLOXY)-16,23:23,26:24,25-TRIEPOXY-26-HYDROXY-9,19-CYCLOLANOSTAN-3-YL
- [(1'R,3'R,4'R,5'R,6'R,12'S,13'S,16'R,18'S,21'R)-2-Hydroxy-1,4',6',12',17',17'-hexamethyl-18'-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8'-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosane]-3'-yl] acetate
- [(1S,1'R,2S,3'R,4R,4'R,5R,5'R,6'R,10'S,12'S,13'S,16'R,18'S,21'R)-2-hydroxy-1,4',6',12',17',17'-hexamethyl-18'-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-spiro[3,6-dioxabicyclo[3.1.0]hexane-4,8'-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosane]-3'-yl] acetate
- 606-083-5
- beta-D-Xylopyranoside, (3beta,12beta)-12-(acetyloxy)-16,23:23,26:24,25-triepoxy-26-hydroxy-9,19-cycloanostan-3-yl
- beta-D-Xylopyranoside, (3beta,12beta,16beta,23R,24R,25S,26S)-12-(acetyloxy)-16,23:23,26:24,25-triepoxy-26-hydroxy-9,19-cyclolanostan-3-yl